1. A composition comprising: - at least one therapeutically active agent, - at least one surface-active agent, - at least one ester of a polycarboxylic acid u non-aqueous sredu.2. A composition according to claim 1, characterized in that said at least one therapeutically active agent is characterized by poor or negligible absorption in the gastrointestinal trakte.3. A composition according to claim 1, characterized in that said at least one therapeutically active agent is makromolekuloy.4. A composition according to claim 1, characterized in that said at least one surface active agent selected from fatty acid or salt thereof, a bile acid or its salts, abietic acid or a salt thereof, or any sochetaniya.5. A composition according to claim 1, characterized in that said non-aqueous medium comprises at least one mono-, oligo- or polyhydric alcohol or any sochetanie.6. A composition according to claim 1, characterized in that said at least one complex of a polycarboxylic acid ether ester is selected from C1-C8-alkyl, and C6-C10-aromatic compound efira.7. A composition according to claim 1, characterized in that it is intended for oral administration of said at least one therapeutically active agenta.8. A composition according to claim 1, characterized in that it comprises at least one therapeutically active agent at least one decanoic acid, lauric acid or any salt thereof propylene glycol and trietiltsitrat.9. A composition comprising: - at least one therapeutically active agent, - at least one surface-active agent, - at least one ester of a polycarboxylic1. Композиция, содержащая:- по меньшей мере один терапевтически активный агент- по меньшей мере один поверхностно-активный агент- по меньшей мере один сложный эфир поликарбоновой кислоты и- неводную среду.2. Композиция по п.1, отличающаяся тем, что указанный, по меньшей мере, один терапевтически активный агент характеризуется плохим или пренебрежимо малым всасыванием в желудочно-кишечном тракте.3. Композиция по п.1, отли
